{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:11:17Z","timestamp":1788012677321,"version":"build-2784847793"},"reference-count":70,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,8,25]]},"DOI":"10.1253\/circj.cj-24-0706","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:06:18Z","timestamp":1747073178000},"page":"1447-1452","source":"Crossref","is-referenced-by-count":9,"title":["Calcific Aortic Valve Disease\u3000\u2015 From Mechanism to Treatment \u2015"],"prefix":"10.1253","volume":"89","author":[{"given":"Yuhe","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"},{"name":"Beijing Laboratory for Cardiovascular Precision Medicine"},{"name":"Key Laboratory of Medical Engineering for Cardiovascular Disease, Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"},{"name":"Beijing Laboratory for Cardiovascular Precision Medicine"},{"name":"Key Laboratory of Medical Engineering for Cardiovascular Disease, Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University"},{"name":"Beijing Laboratory for Cardiovascular Precision Medicine"},{"name":"Key Laboratory of Medical Engineering for Cardiovascular Disease, Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017. <i>Circulation<\/i> 2020; 141: 1670\u20131680.","DOI":"10.1161\/CIR.0000000000000848"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shu S, Yang Y, Sun B, Su Z, Fu M, Xiong C, et al. Alerting trends in epidemiology for calcific aortic valve disease, 1990\u20132019: An age-period-cohort analysis for the Global Burden of Disease Study 2019. <i>Eur Heart J Qual Care Clin Outcomes<\/i> 2023; 9: 459\u2013473.","DOI":"10.1093\/ehjqcco\/qcad018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sugiyama Y, Moriyama N, Miyashita H, Yokoyama H, Ochiai T, Shishido K, et al. Long-term assessment of survival after transcatheter aortic valve implantation: Insights from the International Transcatheter Aortic Valve Implantation Registry. <i>Circ J<\/i> 2024; 88: 462\u2013471.","DOI":"10.1253\/circj.CJ-23-0593"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ran L, Fu Z, Yao J, Yan Y, Song G. Transcatheter aortic valve replacement for aortic regurgitation: A review. <i>CVIA<\/i> 2023, doi:10.15212\/CVIA.2023.0033.","DOI":"10.15212\/CVIA.2023.0033"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Nguyen KQ, Nguyen DV, La TT, Nguyen TV, Than TNH, Nguyen TN, et al. Transcatheter aortic valve replacement in patients \u226580 and &lt;80 years of age with aortic valve stenosis at moderate surgical risk: Findings from an observational study in the Vietnamese population. <i>CVIA<\/i> 2024, doi:10.15212\/CVIA.2024.0003.","DOI":"10.15212\/CVIA.2024.0003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hachiro K, Takashima N, Suzuki T. Long-term outcomes after aortic valve replacement for aortic valve regurgitation: Importance of left ventricular end-systolic diameter. <i>Circ J<\/i> 2024; 88: 1955\u20131961.","DOI":"10.1253\/circj.CJ-24-0081"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Otto CM, Newby DE, Hillis GS. Calcific aortic stenosis: A review. <i>JAMA<\/i> 2024; 332: 2014\u20132026.","DOI":"10.1001\/jama.2024.16477"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsushita K, Morel O, Ohlmann P. Contemporary issues and lifetime management in patients underwent transcatheter aortic valve replacement. <i>Cardiovasc Interv Ther<\/i> 2023; 38: 275\u2013286.","DOI":"10.1007\/s12928-023-00924-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sa MP, Ramlawi B, Sicouri S, Torregrossa G, Al Abri Q, Kempfert J, et al. Lifetime management of aortic valve disease: Aligning surgical and transcatheter armamentarium to set the tone for the present and the future. <i>J Card Surg<\/i> 2022; 37: 205\u2013213.","DOI":"10.1111\/jocs.16110"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Marquis-Gravel G, Redfors B, Leon MB, Genereux P. Medical treatment of aortic stenosis. <i>Circulation<\/i> 2016; 134: 1766\u20131784.","DOI":"10.1161\/CIRCULATIONAHA.116.023997"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bakaeen FG, Rosengart TK, Carabello BA. Aortic stenosis. <i>Ann Intern Med<\/i> 2017; 166: ITC1\u2013ITC16.","DOI":"10.7326\/AITC201701030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zheng KH, Tzolos E, Dweck MR. Pathophysiology of aortic stenosis and future perspectives for medical therapy. <i>Cardiol Clin<\/i> 2020; 38: 1\u201312.","DOI":"10.1016\/j.ccl.2019.09.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Akahori H, Tsujino T, Masuyama T, Ishihara M. Mechanisms of aortic stenosis. <i>J Cardiol<\/i> 2018; 71: 215\u2013220.","DOI":"10.1016\/j.jjcc.2017.11.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Peeters F, Meex SJR, Dweck MR, Aikawa E, Crijns H, Schurgers LJ, et al. Calcific aortic valve stenosis: Hard disease in the heart: A biomolecular approach towards diagnosis and treatment. <i>Eur Heart J<\/i> 2018; 39: 2618\u20132624.","DOI":"10.1093\/eurheartj\/ehx653"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dayawansa NH, Baratchi S, Peter K. Uncoupling the vicious cycle of mechanical stress and inflammation in calcific aortic valve disease. <i>Front Cardiovasc Med<\/i> 2022; 9: 783543.","DOI":"10.3389\/fcvm.2022.783543"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. New SE, Aikawa E. Cardiovascular calcification: An inflammatory disease. <i>Circ J<\/i> 2011; 75: 1305\u20131313.","DOI":"10.1253\/circj.CJ-11-0395"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fernandez Esmerats J, Heath J, Jo H. Shear-sensitive genes in aortic valve endothelium. <i>Antioxid Redox Signal<\/i> 2016; 25: 401\u2013414.","DOI":"10.1089\/ars.2015.6554"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Parisi V, Leosco D, Ferro G, Bevilacqua A, Pagano G, de Lucia C, et al. The lipid theory in the pathogenesis of calcific aortic stenosis. <i>Nutr Metab Cardiovasc Dis<\/i> 2015; 25: 519\u2013525.","DOI":"10.1016\/j.numecd.2015.02.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. <i>Atherosclerosis<\/i> 2018; 277: 60\u201365.","DOI":"10.1016\/j.atherosclerosis.2018.08.029"},{"key":"20","unstructured":"20. Mosch J, Gleissner CA, Body S, Aikawa E. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. <i>Histol Histopathol<\/i> 2017; 32: 293\u2013306."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Iqbal F, Schlotter F, Becker-Greene D, Lupieri A, Goettsch C, Hutcheson JD, et al. Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity. <i>Eur Heart J<\/i> 2023; 44: 885\u2013898.","DOI":"10.1093\/eurheartj\/ehac818"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. He YB, Guo JH, Wang C, Zhu D, Lu LM. IL-33 promotes the progression of nonrheumatic aortic valve stenosis via inducing differential phenotypic transition in valvular interstitial cells. <i>J Cardiol<\/i> 2020; 75: 124\u2013133.","DOI":"10.1016\/j.jjcc.2019.06.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schlotter F, Halu A, Goto S, Blaser MC, Body SC, Lee LH, et al. Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease. <i>Circulation<\/i> 2018; 138: 377\u2013393.","DOI":"10.1161\/CIRCULATIONAHA.117.032291"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sacks MS, David Merryman W, Schmidt DE. On the biomechanics of heart valve function. <i>J Biomech<\/i> 2009; 42: 1804\u20131824.","DOI":"10.1016\/j.jbiomech.2009.05.015"},{"key":"25","unstructured":"25. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. <i>J Heart Valve Dis<\/i> 2004; 13: 841\u2013847."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hjortnaes J, Goettsch C, Hutcheson JD, Camci-Unal G, Lax L, Scherer K, et al. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. <i>J Mol Cell Cardiol<\/i> 2016; 94: 13\u201320.","DOI":"10.1016\/j.yjmcc.2016.03.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Decano JL, Iwamoto Y, Goto S, Lee JY, Matamalas JT, Halu A, et al. A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling. <i>Cell Rep<\/i> 2022; 39: 110685.","DOI":"10.1016\/j.celrep.2022.110685"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lis GJ, Dubrowski A, Lis M, Solewski B, Witkowska K, Aleksandrovych V, et al. Identification of CD34<sup>+<\/sup>\/PGDFR\u03b1<sup>+<\/sup> valve interstitial cells (VICs) in human aortic valves: Association of their abundance, morphology and spatial organization with early calcific remodeling. <i>Int J Mol Sci<\/i> 2020; 21: 6330.","DOI":"10.3390\/ijms21176330"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Parra-Izquierdo I, Castanos-Mollor I, Lopez J, Gomez C, San Roman JA, Sanchez Crespo M, et al. Lipopolysaccharide and interferon-gamma team up to activate HIF-1\u03b1 via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cells. <i>Biochim Biophys Acta Mol Basis Dis<\/i> 2019; 1865: 2168\u20132179.","DOI":"10.1016\/j.bbadis.2019.04.014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Jover E, Martin-Nunez E, Garaikoetxea M, Matilla L, Blanco-Colio LM, Perez-Saez JM, et al. Sex-dependent expression of galectin-1, a cardioprotective beta-galactoside-binding lectin, in human calcific aortic stenosis. <i>FASEB J<\/i> 2024; 38: e23447.","DOI":"10.1096\/fj.202301832RR"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA. Sex-specific features of calcific aortic valve disease. <i>Int J Mol Sci<\/i> 2020; 21: 5620.","DOI":"10.3390\/ijms21165620"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Saad JM, Ahmed AI, Al-Mallah MH. Aortic valve calcification: Time for a sex- and race-based assessment. <i>Atherosclerosis<\/i> 2022; 355: 50\u201351.","DOI":"10.1016\/j.atherosclerosis.2022.07.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sen U, Sathnur PB, Kundu S, Givvimani S, Coley DM, Mishra PK, et al. Increased endogenous H<sub>2<\/sub>S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. <i>Am J Physiol Cell Physiol<\/i> 2012; 303: C41\u2013C51.","DOI":"10.1152\/ajpcell.00398.2011"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sikura KE, Potor L, Szerafin T, Oros M, Nagy P, Mehes G, et al. Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease. <i>Br J Pharmacol<\/i> 2020; 177: 793\u2013809.","DOI":"10.1111\/bph.14691"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Eva Sikura K, Combi Z, Potor L, Szerafin T, Hendrik Z, Mehes G, et al. Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-\u03baB, a link between inflammation and mineralization. <i>J Adv Res<\/i> 2021; 27: 165\u2013176.","DOI":"10.1016\/j.jare.2020.07.005"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Combi Z, Potor L, Nagy P, Sikura KE, Ditroi T, Juranyi EP, et al. Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H<sub>2<\/sub>S lead to H<sub>2<\/sub>S deficiency in calcific aortic valve disease. <i>Redox Biol<\/i> 2023; 60: 102629.","DOI":"10.1016\/j.redox.2023.102629"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Candellier A, Issa N, Grissi M, Brouette T, Avondo C, Gomila C, et al. Indoxyl-sulfate activation of the AhR-NF-\u03baB pathway promotes interleukin-6 secretion and the subsequent osteogenic differentiation of human valvular interstitial cells from the aortic valve. <i>J Mol Cell Cardiol<\/i> 2023; 179: 18\u201329.","DOI":"10.1093\/ndt\/gfac079.038"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Liu X, Zheng Q, Wang K, Luo J, Wang Z, Li H, et al. Sam68 promotes osteogenic differentiation of aortic valvular interstitial cells by TNF-\u03b1\/STAT3\/autophagy axis. <i>J Cell Commun Signal<\/i> 2023; 17: 863\u2013879.","DOI":"10.1007\/s12079-023-00733-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Witz A, Effertz D, Goebel N, Schwab M, Franke UFW, Torzewski M. Pro-calcifying role of enzymatically modified LDL (eLDL) in aortic valve sclerosis via induction of IL-6 and IL-33. <i>Biomolecules<\/i> 2023; 13: 1091.","DOI":"10.3390\/biom13071091"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zhong G, Su S, Li J, Zhao H, Hu D, Chen J, et al. Activation of Piezo1 promotes osteogenic differentiation of aortic valve interstitial cell through YAP-dependent glutaminolysis. <i>Sci Adv<\/i> 2023; 9: eadg0478.","DOI":"10.1126\/sciadv.adg0478"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Liu H, Yin H, Wang Z, Yuan Q, Xu F, Chen Y, et al. Rho A\/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK\/RUNX2 axis. <i>Cell Death Dis<\/i> 2023; 14: 108.","DOI":"10.1038\/s41419-023-05642-1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Xie W, Shan Y, Wu Z, Liu N, Yang J, Zhang H, et al. Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification. <i>Cell Biol Toxicol<\/i> 2023; 39: 2665\u20132684.","DOI":"10.1007\/s10565-023-09794-w"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Dhayni K, Chabry Y, Henaut L, Avondo C, Boudot C, Ouled-Haddou H, et al. Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2. <i>Cardiovasc Res<\/i> 2023; 119: 2355\u20132367.","DOI":"10.1093\/cvr\/cvad117"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Gollmann-Tepekoylu C, Graber M, Hirsch J, Mair S, Naschberger A, Polzl L, et al. Toll-like receptor 3 mediates aortic stenosis through a conserved mechanism of calcification. <i>Circulation<\/i> 2023; 147: 1518\u20131533.","DOI":"10.1161\/CIRCULATIONAHA.122.063481"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Deng H, Li H, Liu Z, Shen N, Dong N, Deng C, et al. Pro-osteogenic role of interleukin-22 in calcific aortic valve disease. <i>Atherosclerosis<\/i> 2024; 388: 117424.","DOI":"10.1016\/j.atherosclerosis.2023.117424"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Fang J, Qian Y, Chen J, Xu D, Cao N, Zhu G, et al. Human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease. <i>Cardiovasc Res<\/i> 2023; 119: 2117\u20132129.","DOI":"10.1093\/cvr\/cvad077"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Xiong J, Lin W, Yuan C, Bian J, Diao Y, Xu X, et al. SIRT6-mediated Runx2 downregulation inhibits osteogenic differentiation of human aortic valve interstitial cells in calcific aortic valve disease. <i>Eur J Pharmacol<\/i> 2024; 968: 176423.","DOI":"10.1016\/j.ejphar.2024.176423"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Viegas CS, Simes DC, Laize V, Williamson MK, Price PA, Cancela ML. Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. <i>J Biol Chem<\/i> 2008; 283: 36655\u201336664.","DOI":"10.1074\/jbc.M802761200"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Viegas CS, Rafael MS, Enriquez JL, Teixeira A, Vitorino R, Luis IM, et al. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 399\u2013408.","DOI":"10.1161\/ATVBAHA.114.304823"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Berkner KL, Runge KW. Vitamin K-dependent protein activation: Normal gamma-glutamyl carboxylation and disruption in disease. <i>Int J Mol Sci<\/i> 2022; 23: 5759.","DOI":"10.3390\/ijms23105759"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Palaniswamy C, Sekhri A, Aronow WS, Kalra A, Peterson SJ. Association of warfarin use with valvular and vascular calcification: A review. <i>Clin Cardiol<\/i> 2011; 34: 74\u201381.","DOI":"10.1002\/clc.20865"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Brandenburg VM, Reinartz S, Kaesler N, Kruger T, Dirrichs T, Kramann R, et al. Slower progress of aortic valve calcification with vitamin K supplementation: Results from a prospective interventional proof-of-concept study. <i>Circulation<\/i> 2017; 135: 2081\u20132083.","DOI":"10.1161\/CIRCULATIONAHA.116.027011"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. S\u00f8nderskov PS, Lindholt JS, Hallas J, Gerke O, Hasific S, Lambrechtsen J, et al. Association of aortic valve calcification and vitamin K antagonist treatment. <i>Eur Heart J Cardiovasc Imaging<\/i> 2020; 21: 718\u2013724.","DOI":"10.1093\/ehjci\/jeaa065"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Diederichsen ACP, Lindholt JS, Moller S, Ovrehus KA, Auscher S, Lambrechtsen J, et al. Vitamin K2 and D in patients with aortic valve calcification: A randomized double-blinded clinical trial. <i>Circulation<\/i> 2022; 145: 1387\u20131397.","DOI":"10.1161\/CIRCULATIONAHA.121.057008"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Omarjee L. Letter by Omarjee regarding article, \u201cVitamin K2 and D in patients with aortic valve calcification: A randomized double-blinded clinical trial\u201d. <i>Circulation<\/i> 2022; 146: e225\u2013e226.","DOI":"10.1161\/CIRCULATIONAHA.122.060855"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Hariri E, Kassis N, Kapadia SR. Letter by Hariri et al regarding article, \u201cVitamin K2 and D in patients with aortic valve calcification: A randomized double-blinded clinical trial\u201d. <i>Circulation<\/i> 2023; 148: 1267\u20131268.","DOI":"10.1161\/CIRCULATIONAHA.123.064607"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. <i>J Am Coll Cardiol<\/i> 2007; 49: 554\u2013561.","DOI":"10.1016\/j.jacc.2006.07.072"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. <i>J Am Coll Cardiol<\/i> 2018; 71: 177\u2013192.","DOI":"10.1016\/j.jacc.2017.11.014"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Tsimikas S, Viney NJ, Hughes SG, Singleton W, Graham MJ, Baker BF, et al. Antisense therapy targeting apolipoprotein(a): A randomised, double-blind, placebo-controlled phase 1 study. <i>Lancet<\/i> 2015; 386: 1472\u20131483.","DOI":"10.1016\/S0140-6736(15)61252-1"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. O\u2019Brien KD, Probstfield JL, Caulfield MT, Nasir K, Takasu J, Shavelle DM, et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. <i>Arch Intern Med<\/i> 2005; 165: 858\u2013862.","DOI":"10.1001\/archinte.165.8.858"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Schmidt N, Brandsch C, Schutkowski A, Hirche F, Stangl GI. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. <i>J Nutr<\/i> 2014; 144: 638\u2013646.","DOI":"10.3945\/jn.113.189118"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Dishmon DA, Dotson JL, Munir A, Nelson MD, Bhattacharya SK, Cruz IAD, et al. Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy. <i>Am J Med Sci<\/i> 2009; 337: 312\u2013316.","DOI":"10.1097\/MAJ.0b013e3181907add"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Kim IY, Ye BM, Kim MJ, Kim SR, Lee DW, Kim HJ, et al. 1,25-Dihydroxyvitamin D deficiency is independently associated with cardiac valve calcification in patients with chronic kidney disease. <i>Sci Rep<\/i> 2022; 12: 915.","DOI":"10.1038\/s41598-022-04981-x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Kassis N, Hariri EH, Karrthik AK, Ahuja KR, Layoun H, Saad AM, et al. Supplemental calcium and vitamin D and long-term mortality in aortic stenosis. <i>Heart<\/i> 2022; 108: 964\u2013972.","DOI":"10.1136\/heartjnl-2021-320215"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Xia C, Lei W, Hu Y, Yang H, Zeng X, Chen M. Association of serum levels of calcium, phosphate, and vitamin D with risk of developing aortic stenosis: The UK Biobank cohort. <i>Eur J Prev Cardiol<\/i> 2022; 29: 1520\u20131528.","DOI":"10.1093\/eurjpc\/zwac016"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Synetos A, Toutouzas K, Drakopoulou M, Koutagiar I, Benetos G, Kotronias R, et al. Inhibition of aortic valve calcification by local delivery of zoledronic acid: An experimental study. <i>J Cardiovasc Transl Res<\/i> 2018; 11: 192\u2013200.","DOI":"10.1007\/s12265-018-9802-4"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Pawade TA, Doris MK, Bing R, White AC, Forsyth L, Evans E, et al. Effect of denosumab or alendronic acid on the progression of aortic stenosis: A double-blind randomized controlled trial. <i>Circulation<\/i> 2021; 143: 2418\u20132427.","DOI":"10.1161\/CIRCULATIONAHA.121.053708"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ferrer MD, Perez MM, Canaves MM, Buades JM, Salcedo C, Perello J. A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma. <i>Sci Rep<\/i> 2017; 7: 6858.","DOI":"10.1038\/s41598-017-07203-x"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Zabirnyk A, Ferrer MD, Bogdanova M, Perez MM, Salcedo C, Kaljusto ML, et al. SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification. <i>Vascul Pharmacol<\/i> 2019; 122\u2013123: 106583.","DOI":"10.1016\/j.vph.2019.106583"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Raggi P, Bellasi A, Bushinsky D, Bover J, Rodriguez M, Ketteler M, et al. Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: Results of a randomized phase 2b study. <i>Circulation<\/i> 2020; 141: 728\u2013739.","DOI":"10.1161\/CIRCULATIONAHA.119.044195"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/9\/89_CJ-24-0706\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T03:25:02Z","timestamp":1756524302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/9\/89_CJ-24-0706\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0706","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"article-number":"CJ-24-0706"}}